Our data are consistent with our recent suggestion9 that cellular pathways, other than changes in GlcCer or GlcSph levels, need to be unearthed in order to delineate the mechanistic association between GBA mutations and PD, including up-stream GSLs in the catabolic pathway such as gangliosides. The gene discussed is GBA1; the disease is Parkinson disease.